An educational workshop on the early detection of prostate cancer: a before-after evaluation

Abstract

Australian population based screening for prostate cancer with prostate specific antigen (PSA) testing is not recommended because of lack of evidence that it reduces its death rate. However, this is controversial, and there is emerging weak evidence for such benefit.